Drug Profile
Galamustine
Alternative Names: G Mustard; Galactose 6-mustardLatest Information Update: 11 Jan 2008
Price :
$50
*
At a glance
- Originator Georgetown University
- Developer Unimed Pharmaceuticals
- Class Antineoplastics; Small molecules
- Mechanism of Action DNA inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 11 Jan 2008 Discontinued - Phase-I for Cancer in United Kingdom (unspecified route)
- 11 Jan 2008 Discontinued - Phase-I for Cancer in USA (unspecified route)
- 09 Nov 2000 No-Development-Reported for Cancer in United Kingdom (Unknown route)